What Higher NAD+ Does, and What Remains Unproved

What raised blood levels leave unanswered

Blood NAD+ consistently rose during human NMN and NR treatment trials. The body converts both tested substances into NAD+. Some trials also found better walking or better muscle sugar use. Those improvements matter, but don't establish longer life or disease prevention. Other trials found a blood change without a clear health benefit. The blood result answers a smaller question than the aging claim.

A raised blood level doesn't prove a lasting health gain.

NAD+ supports fuel supply and repairs within the body's cells. DNA repairs help protect the instructions that guide cell work. Certain proteins spend NAD+ while doing these repair and control jobs. Aging and inflammation can increase that spending, leaving less available ^[4]. Inflammation is part of the way your body handles injury or illness.

A 2025 review in Nature Metabolism gathered human study findings. Benefits remained limited, and researchers knew little about changes within particular organs ^[1]. A blood test cannot settle what happens across your body. This page describes the research and gives no personal treatment amount.

How NAD+ works, and how product rules differ

NAD+ has two linked chemical parts and changes form during cell work. One part receives electrons, tiny charged particles that help transfer energy. NAD+ then becomes NADH, which carries those particles onward. This exchange helps turn the food cells receive into usable fuel. The process already occurs in the body, without an aging treatment.

A natural role doesn't establish the safety of an added product.

NAD+, NMN, NR, and nicotinamide are sold as supplements. Nicotinamide is another substance that the body can convert into NAD+. None of these products has FDA approval as a drug. FDA has disputed NMN's place among legally sold supplements. Studying a substance as a drug can limit later supplement sales. That earlier drug research is the stated reason for the NMN dispute ^[4]. Some clinics give pharmacy-made NAD+ through a vein, also without drug approval. Bacterial contamination prompted a Class I recall, the most serious recall level.

What NAD+ supplies for fuel and repairs

Energy comes first among NAD+'s well-established jobs inside a cell. Breaking down food releases electrons, tiny charged particles that transfer energy. NAD+ receives the particles and changes into the related form NADH. NADH delivers the particles to energy-producing parts within each cell. The cell needs that fuel to keep working. Scientists have long known how NAD+ supports fuel production. This is ordinary body work, rather than evidence of an aging treatment.

Repair work spends NAD+, while fuel work changes its form.

Several kinds of protein need NAD+ to maintain and repair cells. Some help cells control which DNA instructions are put to work. That control affects energy supply and the response to shortages. Other proteins help repair damage to the DNA itself. The immune system uses NAD+ too, while defending the body. Some NAD+-using proteins work harder as aging and inflammation increase ^[4].

Researchers suspect that higher spending leaves less NAD+ for needed repairs. The shortage might also make it harder to maintain energy supply. NMN and NR could replace some of the lost NAD+. Animal experiments give reasons to test that possibility in people. They don't settle whether replacing NAD+ helps your health. Human testing must answer that question separately from explaining cell work.

What changed in blood, walking, and muscle

Blood tests. Healthy overweight adults swallowed NR during a comparison trial. NR's full name is nicotinamide riboside chloride; NIAGEN was the tested product. Chance assigned the adults to NR or a placebo group. Placebo treatment left out NR, letting researchers compare effects. Adults and assessing staff didn't know the assigned group. The trial ran for 8 weeks. Amounts are in mg/day, meaning milligrams each day. Blood changes followed these amounts:

• 100 mg/day went with a 22% rise in blood NAD+.
• 300 mg/day went with a 51% rise in blood NAD+.
• 1000 mg/day went with a 142% rise in blood NAD+.

Nobody had flushing, the hot red skin that plain niacin can cause. Niacin is a vitamin. Unwanted effects didn't differ clearly between NR and placebo ^[5].

Blood changes left lasting benefits unsettled.

Walking and daily well-being. Another trial enrolled healthy adults in middle age across several centers. Chance assigned groups; adults and assessing staff didn't know assignments. Adults swallowed NMN at three tested amounts for 60 days. Blood NAD+ rose in every NMN group at days 30 and 60. Larger amounts produced larger rises than placebo. Adults walked farther and gave better ratings of their daily well-being. The summary calls 600 mg/day best without naming the deciding result. That means milligrams each day studied, without establishing your amount. No safety problems appeared at any tested amount ^[2].

Muscle sugar use. Women after menopause, when monthly periods stop, swallowed NMN for ten weeks. Their blood sugar was above normal, but not high enough to be diabetes. Insulin, a hormone released by the body, helped muscle receive sugar more readily. Researchers checked the response while controlling insulin and blood sugar. Insulin's effects inside muscle changed too. The women's fat and muscle amounts remained unchanged. The test showing average blood sugar stayed unchanged. The improvement concerned muscle, rather than sugar use across the whole body ^[3].

Human findings taken together. A 2025 review gathered human aging trial results. Nature Metabolism, a science journal, published the review in 2025. Health benefits remained limited, despite clearer blood findings. Only a few studies consistently found NAD+ falling with human age. Researchers knew little about how levels change within particular organs. The review called for human tests beyond rodent findings ^[1].

Why researchers tested replacement. Another review examined competition for NAD+ inside cells. Proteins spend NAD+ on repairs and necessary cell work. A declining supply could make the competition more harmful with age ^[4]. That explanation establishes no treatment benefit.

What can cause harm, and what benefits remain uncertain

Lasting health. NMN and NR trials reliably increased blood NAD+. The trials haven't established longer life or lasting protection against illness. Preserving heart health and thinking ability remains unproved ^[1]. The largest aging improvements have come from mouse experiments. A 2025 review cautioned that those results may not apply to people ^[1].

An improved blood test still leaves your main health question open.

Swallowed products. Cells absorb little NAD+ from ordinary capsules when NAD+ stays whole. NMN and NR make more sense for studies of swallowed products. Your body can turn both substances into NAD+ after swallowing. Plain NAD+ capsules may barely raise NAD+ inside cells ^[4]. That explains why studies choose different substances; it doesn't establish treatment benefits.

Liquid through a vein. Added NAD+ quickly leaves plasma, the liquid part of blood. That finding doesn't tell us where all the added NAD+ goes. Leaving blood quickly doesn't establish that NAD+ reaches the cells needing it. Giving NAD+ too quickly can cause chest discomfort, flushing, and nausea. Bacterial toxins also prompted a Class I recall of pharmacy-made NAD+. Class I is the most serious recall level ^[4].

Existing cancer. NAD+ supports cell growth, including the growth of cancer cells. Researchers worry that extra NAD+ could support growth in an existing cancer. NAD+'s effects in cancer depend on the circumstances. This remains a possible harm, rather than an established patient finding ^[4].

Product contents and rules. FDA disputes NMN's status as a supplement, leaving sales rules uncertain ^[4]. Supplement contents and purity also differ between products. Independent testing isn't always required or done. A label cannot assure you of everything actually inside the product.

What human testing adds to aging claims

NAD+ research has more direct human trials than MOTS-c research. Researchers gave people NMN or NR and compared their results. Blood NAD+ rose; other checks measured walking distance and muscle response to sugar ^[2][3][5]. Those are findings about people, with clear limits on what changed. Preventing disease or improving lasting health calls for further evidence.

Reliable blood changes don't settle whether added NAD+ helps you age well.

The 2025 review ^[1] described limited benefits and a need for more studies. The review didn't dismiss the reasons for testing replacement. MOTS-c has a different role, carrying messages that change muscle work. NAD+ supplies energy and repairs; MOTS-c helps cells respond to strain. Here strain means trouble meeting energy needs, rather than worry. The comparison of the human and animal tests shows the remaining gaps. A change inside cells still needs testing for lasting health benefits.